Patents expiring in 2028

US 7425218

Nitric oxide-releasing medical devices

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7425644

Method of purifying pravastatin

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7425611

Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427408

Quorum sensing and biofilm formation

The Regents of the University of California · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427681

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427630

Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

Neurocrine Biosciences, Inc. · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427389

Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes

Provectus Pharmatech, Inc. · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427590

Neurothrophic components of the ADNF I complex

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427598

Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427671

Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and method of making

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427394

Biodegradable poly(β-amino esters) and uses thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427496

Anti-cancer compounds

The Regents of the University of Colorado · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427639

β2-adrenergic receptor agonists

Theravance, Inc. · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427602

Sustained DNA delivery from structural matrices

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429596

1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof

The Regents of the University of California · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429559

Controlled release composition and method of producing the same

Takeda Pharmaceutical Company Limited · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429457

Id-1 and Id-2 genes and products as markers of epithelial cancer

The Regents of the University of California · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429616

Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

The Board of Regents of the University of Texas System · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429238

Systems and methods for the generation of crystalline polymorphs

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429374

Process for the measurement of the potency of glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429485

Method of producing infectious reovirus

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429387

Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

The Regents of the University of Colorado · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429571

Therapeutic furopyrimidines and thienopyrimidines

BioCryst Pharmaceuticals, Inc. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429562

Cyclosporin analog formulations

Isotechnika, Inc. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432330

Hydrolytically stable maleimide-terminated polymers

Nektar Therapeutics AL, Corporation · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432331

Hydrolytically stable maleimide-terminated polymers

Nektar Therapeutics AL, Corporation · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432093

Soluble, functional apoptotic protease-activating factor 1 fragments

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432292

Sulfhydantoins as phosphate isosteres

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432300

Gossypol co-crystals and the use thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7431915

Peptides whose uptake by cells is controllable

The Regents of the University of California · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7431929

Use of vaccinia virus deleted for the E3L gene as a vaccine vector

THE ARIZONA BOARD OF REGENTS · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432304

Small molecule antagonists of Bcl-2 family proteins

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432349

Tumor suppressor gene, p28ING5

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432236

Vasostatin as marrow protectant

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7431942

Orally disintegrable tablets

Takeda Pharmaceutical Company Limited · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432290

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432242

Inhibitors of RGS proteins

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432047

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7431931

Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7431932

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432067

Methods of detection of MATER protein autoantibodies

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7435755

CDDO-compounds and combination therapies thereof

The Board of Regents of the University of Texas System · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7435741

2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7435814

2,4-Pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7435733

Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7435742

Quinuclidine derivatives and pharmaceutical compositions containing the same

Laboratories Almirall, S.A. · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7435801

Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439323

Cysteine-containing peptides having antioxidant properties

The Regents of the University of California · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)